Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine
Cell Reports · 2023-07 · 42 (7) · 112780
DOI: 10.1016/j.celrep.2023.112780 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2023-07. Verfasst von Felipe Lopes de Assis und 19 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: 2019-nCoV Vaccine mRNA-1273, COVID-19. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, Intramural NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Protective immunity following vaccination is sustained by long-lived antibody-secreting cells and resting memory B cells (MBCs). Responses to two-dose SARS-CoV-2 mRNA-1273 vaccination are evaluated longitudinally by multimodal single-cell analysis in three infection-naïve individuals. Integrated surface protein, transcriptomics, and B cell receptor (BCR) repertoire analysis of sorted plasmablasts and spike+ (S-2P+) and S-2P- B cells reveal clonal expansion and accumulating mutations among S-2P+ cells. These cells are enriched in a cluster of immunoglobulin G-expressing MBCs and evolve along a bifurcated trajectory rooted in CXCR3+ MBCs. One branch leads to CD11c+ atypical MBCs while the other develops from CD71+ activated precursors to resting MBCs, the dominant population at month 6. Among 12 evolving S-2P+ clones, several are populated with plasmablasts at early timepoints as well as CD71+ activated and resting MBCs at later timepoints, and display intra- and/or inter-cohort BCR convergence. These relationships suggest a coordinated and predictable evolution of SARS-CoV-2 vaccine-generated MBCs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Immunoregulation, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Pathology, Yale School of Medicine, New Haven, CT 06520, USA.
- Integrated Data Sciences Section, Research Technologies Branch, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
- NIH Center for Human Immunology, NIAID, NIH, Bethesda, MD 20892, USA.
- Multiscale Systems Biology Section, Laboratory of Immune System Biology, NIAID, NIH, Bethesda, MD 20892, USA.
- Institute for Bioscience and Biotechnology Research, Rockville, MD 20850, USA.
Förderung
- NIAID NIH HHS
- Intramural NIH HHS
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases
Zitieren
APA
Lopes de Assis, F., Hoehn, K. B., Zhang, X., Kardava, L., Smith, C. D., El Merhebi, O., Buckner, C. M., Trihemasava, K., Wang, W., Seamon, C. A., Chen, V., Schaughency, P., Cheung, F., Martins, A. J., Chiang, C. I., Li, Y., Tsang, J. S., Chun, T. W., Kleinstein, S. H., & Moir, S. (2023). Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine. Cell Reports, 42(7), 112780. https://doi.org/10.1016/j.celrep.2023.112780
Vancouver
Lopes de Assis F, Hoehn KB, Zhang X, Kardava L, Smith CD, El Merhebi O, et al. Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine. Cell Reports. 2023;42(7):112780. doi:10.1016/j.celrep.2023.112780
BibTeX
@article{LopesdeAssis2023,
author = {Lopes de Assis, Felipe and Hoehn, Kenneth B and Zhang, Xiaozhen and Kardava, Lela and Smith, Connor D and El Merhebi, Omar and Buckner, Clarisa M and Trihemasava, Krittin and Wang, Wei and Seamon, Catherine A and Chen, Vicky and Schaughency, Paul and Cheung, Foo and Martins, Andrew J and Chiang, Chi-I and Li, Yuxing and Tsang, John S and Chun, Tae-Wook and Kleinstein, Steven H and Moir, Susan},
title = {Tracking B cell responses to the SARS-CoV-2 mRNA-1273 vaccine},
journal = {Cell Reports},
year = {2023},
volume = {42},
number = {7},
pages = {112780},
doi = {10.1016/j.celrep.2023.112780}
}
EUVIMED